Aktuellt
SENASTE
Redeye is positive that NeoDynamics has shipped its CorePulse needles to 23 hospitals in the UK, Germany and Switzerland with expected arrival during this month. Moreover, the plan is to deliver its VacuPulse needles by mid-year to the centres. Last year, NeoDynamics paused its sales and production of NeoNavia following clinical practitioners' feedback on the needles. Following a fine-tuning of the offering, we are positive that the company is back on track. We reiterate our base case of SEK1.3.
LÄS MER
